^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    milatuzumab (IMMU-115)

    i
    Other names: IMMU-115, hLL1-DOX, hLL1, humanised anti-CD74, hCD74
    Associations
    News
    Trials
    Company:
    Gilead
    Drug class:
    CD74 inhibitor
    Associations
    News
    Trials